199 related articles for article (PubMed ID: 19066962)
1. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
2. Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.
Zhuang PY; Shen J; Zhu XD; Lu L; Wang L; Tang ZY; Sun HC
PLoS One; 2013; 8(5):e64598. PubMed ID: 23737988
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
6. Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Yang Y; Quan ZW; Liu YB; Shen J
Oncotarget; 2014 Nov; 5(22):11121-32. PubMed ID: 25333267
[TBL] [Abstract][Full Text] [Related]
7. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
11. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
13. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
[TBL] [Abstract][Full Text] [Related]
14. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
[TBL] [Abstract][Full Text] [Related]
15. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
18. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
[TBL] [Abstract][Full Text] [Related]
19. [The expression and significance of vascular endothelial growth factor and its receptors in hepatocellular carcinoma cell lines with various metastatic potentialities].
Ai JH; Zheng SG; Zeng YY; Xiong Y; Zhang LD; Dong JH
Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):105-8. PubMed ID: 18304425
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders.
Marini M; Vichi D; Toscano A; Zappoli Thyrion GD; Parretti E; Mello G; Gheri G; Pacini A; Sgambati E
Reprod Fertil Dev; 2007; 19(5):641-51. PubMed ID: 17601412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
